HEALTHJul 9 · 16:20 UTCTHE RIO TIMESMateo Cruz

Brazil Says Paraguay’s Weight-Loss Pens Are Not the Same Drug

Brazil's medicines regulator, Anvisa, stated that Paraguay's weight-loss pens are not equivalent to the drug tirzepatide. Tests by Unicamp's toxicology centre confirmed the presence and concentration of tirzepatide in smuggled vials but did not assess impurities, contaminants, or sterility.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

AnvisaorganizationBrazilplaceParaguayplaceUnicamp toxicology centreorganizationtirzepatidetopicweight-loss penstopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJun 9 · 00:54 UTC
Safety concerns over doctors prescribing experimental weight loss drug not approved by FDA
HEALTHJun 8 · 12:16 UTC
Doctors prescribing weight loss drug not yet approved by FDA, CBS News investigation finds
HEALTHJun 29 · 15:57 UTC
Could Early Tirzepatide Alter the Course of Type 2 Diabetes?
HEALTHJun 29 · 11:47 UTC
Illegal use of 'Reta' weight-loss drug is a 'huge, unregulated human experiment', warn doctors - as jab is linked to liver damage
HEALTHJul 6 · 15:00 UTC
STAT+: Online GLP-1 prescriptions are often fast, easy — and low on clinical oversight